EVFM News and Press, Evofem Biosciences Inc. From 04/14/23

Evofem Appoints Ivy Zhang as Chief Financial Officer and Secretary PR Newswire SAN DIEGO , April 14, 2023 /PRNewswire/ -- Evofem Biosciences, Inc. , (OTCQB: EVFM), the maker of Phexxi® (lactic acid, citric acid and potassium bitartrate), today announced ...

Evofem Wins Phexxi Coverage with Largest Payer in New York with No Prior Authorization Required PR Newswire — Improves Phexxi coverage for more than 5.8 million New York lives — — Year-to-date, Evofem has gained Phexxi coverage for more than ...

Evofem Biosciences Announces Cost Reduction Measures PR Newswire – Company cuts management pay and lowers headcount to decrease operating costs – – Reductions align with corporate goal to reach cash flow break even by year-end 2023 –...

2023-03-09 06:54:28 ET Evofem Biosciences ( OTCQB:EVFM ) has named Albert Altro as interim chief financial officer to replace Jay File, who is leaving the firm to explore other opportunities. Altro holds over 25 years of financial and operational experience including corporate...

Evofem Biosciences Appoints Interim Chief Financial Officer PR Newswire SAN DIEGO , March 9, 2023 /PRNewswire/ -- Evofem Biosciences, Inc. (OTCQB: EVFM) is pleased to announce the appointment of Albert Altro as Interim Chief Financial Officer of the Company. ...

Evofem's Phexxi Contraceptive Gel Added to SimpleHealth Product Offering PR Newswire -- Phexxi is the first and only hormone-free contraceptive offered by reproductive telehealth leader SimpleHealth to its patients -- SAN DIEGO , Feb. 28, 2023 /PRNews...

Evofem Biosciences Announces FDA Orange Book Listing of Two Additional U.S. Patents for Phexxi PR Newswire -- Evofem now has four Orange Book listed patents covering Phexxi into 2033 -- SAN DIEGO , Feb. 27, 2023 /PRNewswire/ -- Evofem Biosciences, Inc....

Contraceptive gel maker Evofem Biosciences ( OTCQB:EVFM ) has decided to pursue strategic alternatives. The company said those alternatives could include a merger, reverse merger, other business combination, sales of assets, licensing, or other strategic transactions Evofem ( OTCQB:...

Evofem Biosciences to Explore Strategic Alternatives to Maximize Shareholder Value PR Newswire SAN DIEGO , Feb. 23, 2023 /PRNewswire/ -- Evofem Biosciences, Inc. (OTCQB: EVFM), announced today that its Board of Directors has unanimously approved a comprehens...

Evofem's Phexxi Contraceptive Gel to be Offered by Female Telehealth Leader Favor (Formerly The Pill Club) PR Newswire -- Phexxi is the first and only hormone-free contraceptive in the Favor product portfolio -- SAN DIEGO , Jan. 12, 2023 /PRNewswire/ -- E...